17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy.

The protective factor of female gender appears to be lost in diabetes; the incidence of diabetes and its complications, including diabetic nephropathy, are equal in women and men. This study examined the effects of estrogen deficiency by ovariectomy (OVX) and replacement with 17beta-estradiol (OVX+E2) on renal function and pathology in the nondiabetic (ND) and streptozotocin (STZ)-induced diabetic (D) rat kidneys for 12 wk. Diabetes was associated with an increase in urine albumin excretion (UAE; ND, 0.39 +/- 0.03; D, 5.9 +/- 0.8 mg/day; P < 0.001), decrease in creatinine clearance (CrCl; ND, 0.69 +/- 0.03; D, 0.43 +/- 0.09 mg x min(-1) x 100 g body wt(-1); P < 0.05), increase in the index of glomerulosclerosis [GSI; ND, 0.01 +/- 0.01; D, 0.15 +/- 0.04 arbitrary units (AU); P < 0.01], tubulointerstitial fibrosis (TIFI; ND, 0.04 +/- 0.04; D, 0.68 +/- 0.2 AU; P < 0.01), and transforming growth factor-beta (TGF-beta) protein expression (ND, 0.61 +/- 0.02; D, 1.25 +/- 0.07 AU; P < 0.01). In the D group, the severity of these changes was augmented with OVX (UAE, 8.1 +/- 0.6 mg/day; CrCl, 0.40 +/- 0.04 mg x min(-1) x 100 g body wt(-1); GSI, 0.29 +/- 0.04 AU; TIFI, 0.90 +/- 0.06 AU; TGF-beta, 1.26 +/- 0.10 AU), whereas E2 replacement attenuated these changes (UAE, 6.3 +/- 0.8 mg/day; CrCl, 0.66 +/- 0.03 mg x min(-1) x 100 g body wt(-1); GSI, 0.06 +/- 0.02 AU; TIFI, 0.36 +/- 0.08 AU; TGF-beta, 0.57 +/- 0.08 AU). We conclude that E2 deficiency increases the severity of renal disease in a diabetic animal model and that E2 replacement is renoprotective by attenuating the decline in renal function and pathology associated with diabetes.

[1]  C. Hinojosa-Laborde,et al.  Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. , 2004, Journal of the American Society of Nephrology : JASN.

[2]  E. Barrett-Connor,et al.  Women and heart disease: the role of diabetes and hyperglycemia. , 2004, Archives of internal medicine.

[3]  M. Cooper,et al.  Use of genetic mouse models in the study of diabetic nephropathy , 2004, Current diabetes reports.

[4]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[5]  C. Torp‐Pedersen,et al.  Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. , 2004, Journal of the American College of Cardiology.

[6]  Richard J. Johnson,et al.  The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. , 2004, The American journal of pathology.

[7]  E. Ritz,et al.  Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats. , 2004, Journal of the American Society of Nephrology : JASN.

[8]  F. Ziyadeh,et al.  Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. , 2003, Seminars in nephrology.

[9]  M. Koulu,et al.  Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion. , 2003, American journal of physiology. Endocrinology and metabolism.

[10]  D. Mikhailidis,et al.  The Effects of Transdermal Estradiol Alone or with Cyclical Dydrogesterone on Markers of Cardiovascular Disease Risk in Postmenopausal Women with Type 2 Diabetes: A Pilot Study , 2003, Angiology.

[11]  L. Gesualdo,et al.  Clinical and therapeutic aspects of diabetic nephropathy. , 2003, Journal of nephrology.

[12]  G. Striker,et al.  Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. , 2003, The American journal of pathology.

[13]  S. Silbiger,et al.  Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. , 2002, Kidney international.

[14]  S. Aoki,et al.  Different Effects of Castration and Estrogen Administration on Glomerular Injury in Spontaneously Hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats , 2002, Nephron.

[15]  B. Howard,et al.  The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study. , 2002, Diabetes care.

[16]  S. Oparil,et al.  Sex hormones and hypertension. , 2002, Cardiovascular research.

[17]  L. Zacharia,et al.  Role of Methoxyestradiols in the Growth Inhibitory Effects of Estradiol on Human Glomerular Mesangial Cells , 2002, Hypertension.

[18]  B V Howard,et al.  Diabetes and cardiovascular disease. , 2002, Annual review of medicine.

[19]  Tetsuya Yamamoto,et al.  Cross-talk between Transforming Growth Factor-β and Estrogen Receptor Signaling through Smad3* , 2001, The Journal of Biological Chemistry.

[20]  A. Thorburn,et al.  Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y , 2001, International Journal of Obesity.

[21]  G. Striker,et al.  Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. , 2001, Journal of the American Society of Nephrology : JASN.

[22]  S. Silbiger,et al.  Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. , 2000, American journal of physiology. Renal physiology.

[23]  Z. Vajo,et al.  Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension , 2000, BJOG : an international journal of obstetrics and gynaecology.

[24]  S. Silbiger,et al.  Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. , 1999, American journal of physiology. Renal physiology.

[25]  M. Cooper,et al.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? , 1999, Kidney international.

[26]  G. Wolf,et al.  Molecular mechanisms of diabetic renal hypertrophy. , 1999, Kidney international.

[27]  H. Parving,et al.  Progression of diabetic nephropathy in normotensive type 1 diabetic patients. , 1999, Kidney international. Supplement.

[28]  S. Silbiger,et al.  Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. , 1999, Kidney international.

[29]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[30]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[31]  G. Remuzzi,et al.  Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes , 1998, BMJ.

[32]  E. Barrett-Connor,et al.  The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus. , 1997, American journal of public health.

[33]  V. Fidler,et al.  Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[34]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[35]  R. Atkins,et al.  The enhancement of aminonucleoside nephrosis by the co-administration of protamine. , 1987, Kidney international.

[36]  E. Rosenmann,et al.  Effect of the Estrogen Antagonist, Tamoxifen, on Development of Glomerulosclerosis in the Cohen Diabetic Rat , 1985, Diabetes.

[37]  L. Yanko,et al.  Female Sex Hormone and Nephropathy in Cohen Diabetic Rat (Genetically Selected Sucrose-Fed) , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[38]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[39]  John M. Lachin,et al.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.

[40]  Z. Nemes,et al.  Estradiol is nephroprotective in the rat remnant kidney. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  S. Goldfarb,et al.  TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy. , 2001, Transactions of the American Clinical and Climatological Association.

[42]  J. Pugh,et al.  Predictors of the rate of renal function decline in non-insulin-dependent diabetes mellitus. , 1997, American journal of nephrology.

[43]  J. D. Neill,et al.  The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. , 1975, Endocrinology.